Dr. Reddy's launches generic Lyrica
Dr. Reddy’s is debuting pregabalin capsules.
The product is the generic of C.P. Pharmaceutical’s Lyrica (pregabalin) capsules.
The branded product had a market value of approximately $5.5 billion for the most recent 12 months ending in May 2019, according to IQVIA.
Dr. Reddy’s pregabalin capsules are available in 25 mg, 50 mg, 75 mg, 100 mg, 150 mg, 200 mg, 225 mg and 300 mg dosage strengths. The capsules are available in bottle count sizes of 90.
The product is the generic of C.P. Pharmaceutical’s Lyrica (pregabalin) capsules.
The branded product had a market value of approximately $5.5 billion for the most recent 12 months ending in May 2019, according to IQVIA.
Dr. Reddy’s pregabalin capsules are available in 25 mg, 50 mg, 75 mg, 100 mg, 150 mg, 200 mg, 225 mg and 300 mg dosage strengths. The capsules are available in bottle count sizes of 90.